What Happened?
Seattle, WA-based Neoleukin Appointed Rob Bickford as Senior Director, Finance
About the Company
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
About the Person
Rob Bickford is Senior Director, Finance at Neoleukin. Previously, Rob held various senior HR leadership roles in the industry.
Info Source
News
Short Profile